News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kissei Pharmaceutical Co., Ltd. To License KGA, Diabetes Drug Candidate, To GlaxoSmithKline (GSK)



4/10/2006 12:23:19 PM

Tokyo, Apr 8, 2006 (JCN) - Kissei Pharmaceutical announced on April 6 that it has concluded a licensing agreement with GlaxoSmithKline (GSK) for KGA, Kissei Pharmaceutical's proprietary candidate compound for diabetes drug.

Read at JCN Newswire


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES